Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis (Q38195430)

30 August 2017

0 references

1 reference

title

Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis (English)

1 reference

30 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

2

Bernard Zinman

1 reference

30 August 2017

Caroline Kaercher Kramer

series ordinal

1

1 reference

PubMed ID

24622264

30 August 2017

Ravi Retnakaran

series ordinal

3

1 reference

30 August 2017

4 February 2013

1 reference

The Lancet: Diabetes & Endocrinology

30 August 2017

1 reference

30 August 2017

1

1 reference

30 August 2017

1

1 reference

30 August 2017

28-34

1 reference

The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality.

30 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Type 2 diabetes across generations: from pathophysiology to prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

beta-cell failure in diabetes and preservation by clinical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Intensive insulin therapy in newly diagnosed type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Short-term intensified insulin treatment in type 2 diabetes: long-term effects on β-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Insulin improves β-cell function in glucose-intolerant rat models induced by feeding a high-fat diet

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Pancreatic beta-cell mass in European subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Effect of short-term intensive insulin therapy on quality of life in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

The response to short-term intensive insulin therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Short-term intensive insulin therapy in newly diagnosed type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

Initial short-term intensive insulin therapy as a strategy for evaluating the preservation of beta-cell function with oral antidiabetic medications: a pilot study with sitagliptin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970006-8

7 January 2021

10.1016/S2213-8587(13)70006-8

Identifiers

DOI

1 reference

30 August 2017

1 reference

PubMed ID

24622264